李小毛,叶辉霞,刘继红,等.术前血清CA19-9在子宫内膜癌评估中的价值[J].中山大学学报(医学科学版),2015,36(2):275-278. LI Xiaomao, YE Huixia, LIU Jihong, et al. Serum Levels of CAl9-9 and Disease Characteristics in Endometrial Cancer[J]. Journal of Sun Yat-Sen University(Medical Sciences), 2015, 36(2):275-278.
[2]
Castel M, Despas F, Modesto A, et al.cardiotoxicity of chemotherapies[J].Presse Med, 2013, 42(1):26-39.
[3]
Schlitt A, Jordan K, Vordermark D, et al. Cardiotoxicity and oncological treatments[J].Dtsch Arztebl Int, 2014, 111(10):161-168.
[4]
Li WJ, Jiang JY, Wang XL.Nedaplatin salvage chemotherapy for cervical cancer[J].Asian Pac J Cancer Prev, 2015, 16(8):3159-3162.
Du J, Hu C, Zhang Y, et al. A retrospective study of paclitaxel combining nedaplatin chemotherapy for esophageal cancer[J]. Anticancer Drugs, 2015, 26(1):101-105.